Medpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024. In the quarter to June 2026, revenue grew 17.2%, EPS grew 36.4% and free cash flow fell 3.03%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for ten.
Follow MEDP
Medpace Holdings, Inc. (MEDP) P/E ratio
As of 16 October 2026, Medpace Holdings, Inc. (MEDP) trades at a P/E ratio of 35.6×. Over the past ten years it has ranged from 0.0× (September 2016) to 96.2× (December 2016); the current reading is higher than 63% of that period. That is in line with the Diagnostics & Research industry median of 35.6× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 35.9× | 40.99% |
| FY2024 | 25.4× | (23.42%) |
| FY2023 | 33.2× | 21.36% |
| FY2022 | 27.4× | (36.37%) |
| FY2021 | 43.0× | 25.76% |
| FY2020 | 34.2× | 13.52% |
| FY2019 | 30.1× | 19.54% |
| FY2018 | 25.2× | (32.14%) |
| FY2017 | 37.1× | (58.87%) |
| FY2016 | 90.3× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 30.5× | 2.99% |
| Mar 2026 | 29.6× | (17.56%) |
| Dec 2025 | 35.9× | 2.26% |
| Sep 2025 | 35.1× | 54.43% |
| 39 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TWST Twist Bioscience Corporation compare | n/m |
| GH Guardant Health, Inc. compare | n/m |
| CRL Charles River Laboratories International, Inc. compare | n/m |
| QGEN QIAGEN N.V. compare | 23.6× |
| DGX Quest Diagnostics Incorporated compare | 24.6× |
| LH Labcorp Holdings Inc. compare | 26.2× |
| MEDP Medpace Holdings, Inc. | 35.6× |
| RVTY Revvity Inc. compare | 72.7× |
| ICLR ICON PLC compare | 254× |
| Diagnostics & Research industry median | 35.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)